Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's presentation is scheduled for Wednesday, January 15, 2025, at 2:15 pm PT. Interested parties can access the live webcast through either a direct link or via the Events and Presentations section of Madrigal's Investor Relations website.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. La presentazione dell'azienda è programmata per mercoledì 15 gennaio 2025, alle 14:15 PT. Le parti interessate possono accedere alla diretta della presentazione tramite un link diretto o attraverso la sezione Eventi e Presentazioni del sito web delle Relazioni con gli Investitori di Madrigal.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha anunciado su participación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. La presentación de la compañía está programada para miércoles, 15 de enero de 2025, a las 2:15 p. m. PT. Las partes interesadas pueden acceder a la transmisión en vivo a través de un enlace directo o a través de la sección de Eventos y Presentaciones en el sitio web de Relaciones con Inversores de Madrigal.
마드리갈 제약(Madrigal Pharmaceuticals) (Nasdaq: MDGL)은 제43회 JP모건 헬스케어 컨퍼런스에 참석할 것이라고 발표했습니다. 회사의 발표는 2025년 1월 15일 수요일, 오후 2시 15분 PT로 예정되어 있습니다. 관심 있는 분들은 직접 링크를 통해 또는 마드리갈 투자자 관계 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 생중계를 시청할 수 있습니다.
Madrigal Pharmaceuticals (Nasdaq: MDGL) a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. La présentation de la société est prévue pour mercredi 15 janvier 2025, à 14h15 PT. Les parties intéressées peuvent accéder à la diffusion en direct via un lien direct ou via la section Événements et Présentations du site des Relations Investisseurs de Madrigal.
Madrigal Pharmaceuticals (Nasdaq: MDGL) hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Die Präsentation des Unternehmens ist für Mittwoch, den 15. Januar 2025, um 14:15 Uhr PT geplant. Interessierte können über einen direkten Link oder über den Abschnitt Veranstaltungen und Präsentationen der Investor Relations-Website von Madrigal auf die Live-Übertragung zugreifen.
- None.
- None.
CONSHOHOCKEN, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The presentation will be webcast live and can be accessed here or by visiting Madrigal’s Investor Relations Site, Events and Presentations.
About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When is Madrigal Pharmaceuticals (MDGL) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Madrigal Pharmaceuticals' (MDGL) J.P. Morgan Healthcare Conference presentation?
Which annual J.P. Morgan Healthcare Conference will MDGL be presenting at in 2025?
Will Madrigal Pharmaceuticals' (MDGL) J.P. Morgan presentation be available for replay?
